- WBPaper00041939:EtBr-exposed_vs_UVC-exposed_3h
Transcripts were defined as fold-change >1.2, p < 0.05 based on Rosetta Resolver analysis for all pairwise treatment comparisons. The fold-change refers to the second intensity over the first.
Genes differentially expressed under EtBr treatment without UVC exposure vs after UVC exposure but without EtBr treatment at the -45h timepoint (3 hours after the first UVC dose).
- WBPaper00061853:osm-3(dh441)_upregulated
DESeq2 1.16.1, FDR < 0.05, fold change > 2.
Transcripts that showed significantly increased expression in osm-3(dh441) comparing to in N2 without tunicamycin treatment.
- WBPaper00061853:osm-3(dh441)_downregulated
DESeq2 1.16.1, FDR < 0.05, fold change > 2.
Transcripts that showed significantly decreased expression in osm-3(dh441) comparing to in N2 without tunicamycin treatment.
- WBPaper00041939:EtBr-exposed_vs_UVC-exposed_48h
Transcripts were defined as fold-change >1.2, p < 0.05 based on Rosetta Resolver analysis for all pairwise treatment comparisons. The fold-change refers to the second intensity over the first.
Genes differentially expressed under EtBr treatment without UVC exposure vs after UVC exposure but without EtBr treatment at the -1h timepoint (just prior to the third UVC dose (48h)).
- WBPaper00041939:EtBr-exposed_vs_UVC-exposed_24h
Transcripts were defined as fold-change >1.2, p < 0.05 based on Rosetta Resolver analysis for all pairwise treatment comparisons. The fold-change refers to the second intensity over the first.
Genes differentially expressed under EtBr treatment without UVC exposure vs after UVC exposure but without EtBr treatment at the -25h timepoint (just prior to the second UVC dose (24h)).
- WBPaper00042067:Cu2+_upregulated_WT
N.A.
Genes up-regulated greater than 2-fold by Cu2+ in wild-type animals, by comparing transcript expression levels between animals with or without Cu2+ treatment.
- WBPaper00041939:EtBr-exposed_vs_UVC-exposed_51h
Transcripts were defined as fold-change >1.2, p < 0.05 based on Rosetta Resolver analysis for all pairwise treatment comparisons. The fold-change refers to the second intensity over the first.
Genes differentially expressed under EtBr treatment without UVC exposure vs after UVC exposure but without EtBr treatment at the -3h timepoint (3 h after the third UVC dose (51h), which is also 3 h after being placed on food).
- WBPaper00059604:fluvastatin_downregulated_N2
DESeq2 FDR < 0.05
Transcripts that showed significantly decreased expression in N2 animals exposed to fluvastatin sodium for 9 hours at L4 larva stage, comparing to N2 animals grown without fluvastatin exposure.
- WBPaper00059604:fluvastatin_upregulated_N2
DESeq2 FDR < 0.05
Transcripts that showed significantly increased expression in N2 animals exposed to fluvastatin sodium for 9 hours at L4 larva stage, comparing to N2 animals grown without fluvastatin exposure.
- WBPaper00058691:CFP-1_interacting_protein
Spectral count (SC) CFP-1 > 3 and a SC control (without CFP-1::GFP transgene) = 0.
Proteins that interact with CFP-1::GFP according to immunoprecipitation followed with mass-spectrometry-based proteomics studies.